Clincosm LogoSign in Get a demo

CBTp: Cognitive Behavioural Therapy-Informed Groups for Psychosis

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05584215
Collaborator
(none)
50
Enrollment
2
Arms
7
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

This is a feasibility study of cognitive behavioural therapy-informed groups for psychiatric inpatients with positive symptoms of psychosis.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioural Therapy for Psychosis Groups
 N/A

Detailed Description

The majority of inpatients at Parkwood Institute Mental Health have symptoms of psychosis. In line with Health Quality Ontario standards for the treatment of psychosis, the investigators would like to implement and evaluate cognitive behavioural therapy for psychosis (CBTp) informed groups. The feasibility, acceptability, and preliminary efficacy of CBTp groups for inpatients will be examined. Pragmatically, the investigators propose to undergo training in CBTp, implement empirically-supported CBTp protocols developed for inpatients, track outcomes, and publish our findings. The investigators would also incorporate patient feedback to improve future iterations of the protocol. Such an undertaking would build research capacity in front line staff by encouraging engagement in CBTp group training, survey design, participant screening, data collection, analyses, and dissemination of findings.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cognitive Behavioural Therapy-Informed Groups for Psychosis
Anticipated Study Start Date :
Jun 3, 2023
Anticipated Primary Completion Date :
Jan 2, 2024
Anticipated Study Completion Date :
Jan 2, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment

Treatment group will receive cognitive behavioural therapy informed groups for psychosis.

Behavioral: Cognitive Behavioural Therapy for Psychosis Groups
Groups based on cognitive behavioural therapy for psychosis
No Intervention: Control

Control group will be put on a waitlist to receive cognitive behavioural therapy informed groups for psychosis.

Outcome Measures

Primary Outcome Measures

  1. Clinical Outcomes in Routine Evaluation 10 (CORE-10) [Up to 2 months]

    The Clinical Outcomes in Routine Evaluation 10 is a short 10 item easy-to-use assessment measure for common presentations of psychological distress, designed to be used for screening as well as over the course of treatment to track progress. The minimum value is 0, the maximum value is 40, and higher scores indicate a worse outcome.

  2. Process of Recovery Questionnaire (QPR) [Up to 2 months]

    The Process of Recovery Questionnaire is a 15 item questionnaire which was co-produced by people who experience psychosis and their accounts of recovery. The minimum value is 0, the maximum value is 60, and higher scores indicate a better outcome.

Secondary Outcome Measures

  1. The Positive and Negative Syndrome Scale (PANSS) - Positive Symptoms [Up to 2 months]

    A brief measure of positive symptoms of psychosis. The minimum value is 7, the maximum values is 49. Higher scores indicate a worse outcome.

Other Outcome Measures

  1. Satisfaction Questionnaire [Up to 2 months]

    Brief open-ended questions about program satisfaction. Responses are qualitative.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • Can read/write in English

  • Has positive symptoms of psychosis that are distressing to them

Exclusion Criteria:
  • Inability to tolerate group participation

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Lawson Health Research Institute

Investigators

  • Principal Investigator: Serena Wong, PhD, Lawson Health Research Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Serena Wong, Principal Investigator, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT05584215
Other Study ID Numbers:
  • 12462
First Posted:
Oct 18, 2022
Last Update Posted:
Jan 27, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Serena Wong, Principal Investigator, Lawson Health Research Institute
cognitive behavioral therapy
Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders

Study Results

No Results Posted as of Jan 27, 2023